Organ Transplant in the Direct-acting Antiviral Era

Severe outcomes may ensue in a high percentage of patients. The authors discuss the consequences in this brief podcast.

Your daily dose of clinical news you may have missed.

Direct-acting antiviral treatment was independently associated with a lower risk of mortality and liver and nonliver outcomes in a large study of adults with chronic hepatitis C.

Timely initiation of DAA treatment, regardless of insurance type, is crucial in reducing HCV-related death, disparity, and transmission, concluded CDC researchers.

IDWeek 2021: Young people who inject drugs can be cured of hepatitis C virus infection, according to 2 new studies.